Nymox Annual Report

IRVINE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its Annual Report is and has been in progress since late February, soon after Nymox received some of its corporate documents withheld by the terminated officers and directors. Unfortunately, this has caused delays beyond the Company’s control in its completion. The Company believes that the audit will be completed soon, and it will issue its annual report as soon as possible thereafter.   Read More

Nymox Annual Report

Nymox Annual Report

Nymox Annual Report

Nymox Annual Report

Nymox Annual Report